| Bioactivity | BMS-196085 is an orally active, potent and selective full agonist against human β3 adrenergic receptor with a Ki value of 21 nM. BMS-196085 also has partial agonist activity at the β1 receptor. BMS-196085 is promising for research of obesity and type-II diabetes[1][2]. |
| CAS | 170686-10-9 |
| Formula | C24H26F2N2O5S |
| Molar Mass | 492.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Gavai A V, et al. BMS-196085: a potent and selective full agonist of the human β3 adrenergic receptor[J]. Bioorganic & medicinal chemistry letters, 2001, 11(23): 3041-3044. [2]. Hu B, et al. Orally bioavailable β3-adrenergic receptor agonists as potential therapeutic agents for obesityand type-II diabetes[J]. Progress in medicinal chemistry, 2003, 41: 167-194. |
BMS-196085
CAS: 170686-10-9 F: C24H26F2N2O5S W: 492.54
BMS-196085 is an orally active, potent and selective full agonist against human β3 adrenergic receptor with a Ki value
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.